ArticlePharmacological research2021

TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.

Érica Aparecida de Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.